Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1504917
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1504917
Active Pharmaceutical Ingredient Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Form; By Manufacturer Type; By Application; By Regions; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global active pharmaceutical ingredient (API) market size is expected to reach USD 315.84 billion by 2032 according to a new study by Polaris Market Research. The report "Active pharmaceutical Ingredient (API) market Share, Size, Trends, Industry Analysis Report, By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others), By Regions; Segment Forecast, 2020 -2027"gives a detailed insight into current market dynamics and provides analysis on future market growth.
Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the human body. Drug products are composed of various components, API is the primary ingredient of a drug product, for instance, capsule or a tablet. APIs form used in the formulation is the most stable crystalline form, thermo-dynamically.
The prominent factors favoring the global market include the sudden outbreak of novel corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth. Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs. For instance, according to a report published in March 2020, by World Health Organization (WHO), the number of COVID-19 patients increased to 200,000 and in almost after twelve-day period, the number would exceed by 100,000. Moreover, rising incidence of cardiovascular, oncology, diabetes and lifestyle diseases coupled with rising geriatric populace is furthermore surging the overall demand for the global market.
Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy's Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the global market.
Players in the market are focusing on developing active pharmaceutical Ingredient to suffice the rising demand of critical drugs for the treatment of numerous diseases. For the treatment of various diseases such as cancer, HIV, arthritis, Hepatitis-B, diabetes, cardiovascular diseases, Aids and various others, which are responsible for the majority of deaths across the globe, the innovation and demand for pharmaceuticals has witnessed elevated graph over the few decades. This has further resulted in rise in growth of API during the past years and also over the forecast period.
Major players in the market are strengthening their capabilities to enhance their product portfolio and further establish their market place. For instance, on July, 2020, Advert International signed an agreement for the acquisition of RA Chem Pharma Ltd, an integrated pharmaceutical company by Micro Labs Ltd. for USD 1.7 billion. Advert International aims for building one of the major API platforms and is expected to leverage their operational and financial resources across the globe to scale RA Chem Pharma.
Polaris Market Research has segmented the Active Pharmaceutical Ingredient market on the basis of product type, form, manufacturer type, application and region
Active Pharmaceutical Ingredient Product Type Outlook (Revenue - USD Million, 2016 - 2027)
- Monoclonal Antibodies
- Immunoglobulin
- Cytokines
- Insulin
- Peptide Hormones
- Blood Factors
- Peptide Antibiotics
- Vaccines
- Small Molecule Antibiotics
- Highly Potent Active Pharmaceutical Ingredient (HPAPI)
- Others
Active Pharmaceutical Ingredient Form Outlook (Revenue - USD Million, 2016 - 2027)
- Aqueous
- Non-Aqueous Liquid
- Dry Powder
Active Pharmaceutical Ingredient Manufacturer Type Outlook (Revenue - USD Million, 2016 - 2027)
- Captive
- Merchant
Active Pharmaceutical Ingredient Application Outlook (Revenue - USD Million, 2016 - 2027)
- Cardiology
- Oncology
- CNS & Neurology
- Orthopedic
- Endocrinology
- Pulmonology
- Gastroenterology
- Nephrology
- Ophthalmology
- Others
Active Pharmaceutical Ingredient Regional Outlook (Revenue - USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Central & South America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM1703
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Active Pharmaceutical Ingredient Market Insights
- 4.1. Active Pharmaceutical Ingredient - Industry snapshot
- 4.2. Active Pharmaceutical Ingredient Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Surge in the infectious diseases
- 4.2.1.2. Growing Importance of Generics
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Side effects associated of drugs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Active Pharmaceutical Ingredient Market Industry trends
5. Active Pharmaceutical Ingredient Market Assessment by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Active Pharmaceutical Ingredient Market, By Product Type, 2015 - 2026 (USD Million)
- 5.3. Monoclonal Antibodies
- 5.3.1. Global Active Pharmaceutical Ingredient Market, by Monoclonal Antibodies, by Region, 2016- 2027 (USD Million)
- 5.4. Immunoglobulin
- 5.4.1. Global Active Pharmaceutical Ingredient Market, by Immunoglobulin, by Region, 2016- 2027 (USD Million)
- 5.5. Cytokines
- 5.5.1. Global Active Pharmaceutical Ingredient Market, by Cytokines, by Region, 2016- 2027 (USD Million)
- 5.6. Insulin
- 5.6.1. Global Active Pharmaceutical Ingredient Market, by Insulin, by Region, 2016- 2027 (USD Million)
- 5.7. Peptide Hormones
- 5.7.1. Global Active Pharmaceutical Ingredient Market, by Peptide Hormones, by Region, 2016- 2027 (USD Million)
- 5.8. Blood Factors
- 5.8.1. Global Active Pharmaceutical Ingredient Market, by Blood Factors, by Region, 2016- 2027 (USD Million)
- 5.9. Peptide Antibiotics
- 5.9.1. Global Active Pharmaceutical Ingredient Market, by Peptide Antibiotics, by Region, 2016- 2027 (USD Million)
- 5.10. Vaccines
- 5.10.1. Global Active Pharmaceutical Ingredient Market, by Vaccines, by Region, 2016- 2027 (USD Million)
- 5.11. Small Molecule Antibiotics
- 5.11.1. Global Active Pharmaceutical Ingredient Market, by Small Molecule Antibiotics, by Region, 2016- 2027 (USD Million)
- 5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
- 5.12.1. Global Active Pharmaceutical Ingredient Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2016- 2027 (USD Million)
- 5.13. Others
- 5.13.1. Global Active Pharmaceutical Ingredient Market, by Others, by Region, 2016- 2027 (USD Million)
6. Global Active Pharmaceutical Ingredient Market, by Form
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Active Pharmaceutical Ingredient Market, By Form, 2015 - 2026 (USD Million)
- 6.3. Aqueous
- 6.3.1. Global Active Pharmaceutical Ingredient Market, by Aqueous, By Region, 2016- 2027 (USD Million)
- 6.4. Non-Aqueous Liquid
- 6.4.1. Global Active Pharmaceutical Ingredient Market, by Non-Aqueous Liquid, by Region, 2016- 2027 (USD Million)
- 6.5. Dry Powder
- 6.5.1. Global Active Pharmaceutical Ingredient Market, by Dry Powder, by Region, 2016- 2027 (USD Million)
7. Global Active Pharmaceutical Ingredient Market, by Manufacturer
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2015 - 2026 (USD Million)
- 7.3. Captive
- 7.3.1. Global Active Pharmaceutical Ingredient Market, by Captive, By Region, 2016- 2027 (USD Million)
- 7.4. Merchant
- 7.4.1. Global Active Pharmaceutical Ingredient Market, by Merchant, by Region, 2016- 2027 (USD Million)
8. Active Pharmaceutical Ingredient Market Assessment by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Active Pharmaceutical Ingredient Market, By Application, 2015 - 2026 (USD Million)
- 8.3. Cardiology
- 8.3.1. Global Active Pharmaceutical Ingredient Market, by Cardiology, by Region, 2016- 2027 (USD Million)
- 8.4. Oncology
- 8.4.1. Global Active Pharmaceutical Ingredient Market, by Oncology, by Region, 2016- 2027 (USD Million)
- 8.5. CNS & Neurology
- 8.5.1. Global Active Pharmaceutical Ingredient Market, by CNS & Neurology, by Region, 2016- 2027 (USD Million)
- 8.6. Orthopedic
- 8.6.1. Global Active Pharmaceutical Ingredient Market, by Orthopedic, by Region, 2016- 2027 (USD Million)
- 8.7. Endocrinology
- 8.7.1. Global Active Pharmaceutical Ingredient Market, by Endocrinology, by Region, 2016- 2027 (USD Million)
- 8.8. Pulmonology
- 8.8.1. Global Active Pharmaceutical Ingredient Market, by Pulmonology, by Region, 2016- 2027 (USD Million)
- 8.9. Gastroenterology
- 8.9.1. Global Active Pharmaceutical Ingredient Market, by Gastroenterology, by Region, 2016- 2027 (USD Million)
- 8.10. Nephrology
- 8.10.1. Global Active Pharmaceutical Ingredient Market, by Nephrology, by Region, 2016- 2027 (USD Million)
- 8.11. Ophthalmology
- 8.11.1. Global Active Pharmaceutical Ingredient Market, by Ophthalmology, by Region, 2016- 2027 (USD Million)
- 8.12. Others
- 8.12.1. Global Active Pharmaceutical Ingredient Market, by Other Applications, by Region, 2016- 2027 (USD Million)
9. Active Pharmaceutical Ingredient Market Assessment by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016- 2027 (USD Million)
- 9.3. Active Pharmaceutical Ingredient Market - North America
- 9.3.1. North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.3.2. North America: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.3.3. North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- 9.3.4. North America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.3.5. Active Pharmaceutical Ingredient Market - U.S.
- 9.3.5.1. U.S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.3.5.2. U.S.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.3.5.3. U.S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.3.5.4. U.S.: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.3.6. Active Pharmaceutical Ingredient Market - Canada
- 9.3.6.1. Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.3.6.2. Canada.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.3.6.3. Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.3.6.4. Canada: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4. Active Pharmaceutical Ingredient Market - Europe
- 9.4.1. Europe: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.2. Europe.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.3. Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.4. Europe: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4.5. Active Pharmaceutical Ingredient Market - UK
- 9.4.5.1. UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.5.2. UK.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.5.3. UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.5.4. UK: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4.6. Active Pharmaceutical Ingredient Market - France
- 9.4.6.1. France: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.6.2. France.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.6.3. France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.6.4. France: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4.7. Active Pharmaceutical Ingredient Market - Germany
- 9.4.7.1. Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.7.2. Germany.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.7.3. Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.7.4. Germany: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4.8. Active Pharmaceutical Ingredient Market - Italy
- 9.4.8.1. Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.8.2. Italy.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.8.3. Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.8.4. Italy: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4.9. Active Pharmaceutical Ingredient Market - Spain
- 9.4.9.1. Spain: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.9.2. Spain.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.9.3. Spain: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.9.4. Spain: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4.10. Active Pharmaceutical Ingredient Market - Netherlands
- 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.10.2. Netherlands.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.4.11. Active Pharmaceutical Ingredient Market - Austria
- 9.4.11.1. Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.4.11.2. Austria.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.4.11.3. Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.4.11.4. Austria: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.5. Active Pharmaceutical Ingredient Market - Asia-Pacific
- 9.5.1. Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.5.2. Asia Pacific.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.5.3. Asia-pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.5.4. Asia-pacific: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.5.5. Active Pharmaceutical Ingredient Market - China
- 9.5.5.1. China: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.5.5.2. China.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.5.5.3. China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.5.5.4. China: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.5.6. Active Pharmaceutical Ingredient Market - India
- 9.5.6.1. India: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.5.6.2. India.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.5.6.3. India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.5.6.4. India: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.5.7. Active Pharmaceutical Ingredient Market - Malaysia
- 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.5.7.2. Malaysia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.5.8. Active Pharmaceutical Ingredient Market - Japan
- 9.5.8.1. Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.5.8.2. Japan.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.5.8.3. Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.5.8.4. Japan: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.5.9. Active Pharmaceutical Ingredient Market - Indonesia
- 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.5.9.2. Indonesia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.5.10. Active Pharmaceutical Ingredient Market - South Korea
- 9.5.10.1. South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.5.10.2. South Korea.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.5.10.3. South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.5.10.4. South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.6. Active Pharmaceutical Ingredient Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.6.2. Middle East & Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.6.5. Active Pharmaceutical Ingredient Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.6.5.2. Saudi Arabia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.6.6. Active Pharmaceutical Ingredient Market - UAE
- 9.6.6.1. UAE: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.6.6.2. UAE.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.6.6.3. UAE: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.6.6.4. UAE: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.6.7. Active Pharmaceutical Ingredient Market - Israel
- 9.6.7.1. Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.6.7.2. Israel.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.6.7.3. Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.6.7.4. Israel: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.6.8. Active Pharmaceutical Ingredient Market - South Africa
- 9.6.8.1. South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.6.8.2. South Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.6.8.3. South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.6.8.4. South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.7. Active Pharmaceutical Ingredient Market - Latin America
- 9.7.1. Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.7.2. Latin America.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.7.3. Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.7.4. Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.7.5. Active Pharmaceutical Ingredient Market - Mexico
- 9.7.5.1. Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.7.5.2. Mexico.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.7.5.3. Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.7.5.4. Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.7.6. Active Pharmaceutical Ingredient Market - Brazil
- 9.7.6.1. Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.7.6.2. Brazil.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.7.6.3. Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.7.6.4. Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
- 9.7.7. Active Pharmaceutical Ingredient Market - Argentina
- 9.7.7.1. Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
- 9.7.7.2. Argentina.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
- 9.7.7.3. Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
- 9.7.7.4. Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion & Acquisition
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. AbbVie Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Albemarle Corporation
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. AstraZeneca
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Aurobindo Pharma
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Boehringer Ingelheim
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Bristol-Myers Squibb
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Cipla Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Dr. Reddy's Laboratories Ltd.
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. ELI Lilly and Company
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. F. Hoffmann-La Roche AG
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. GlaxoSmithKline PLC
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Lonza Group
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Merck & Co., Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Mylan N.V.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Novartis AG
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Pfizer, Inc.
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Sanofi
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
- 11.18. Sun Pharmaceutical Industries Ltd
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development
- 11.19. Teva Pharmaceutical Industries Ltd.
- 11.19.1. Company Overview
- 11.19.2. Financial Performance
- 11.19.3. Product Benchmarking
- 11.19.4. Recent Development
Product Code: PM1703
List of Tables
- Table 1 Global Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 2 Global Active Pharmaceutical Ingredient Market, by Form, by Region, 2016 - 2027 (USD Million)
- Table 3 Global Active Pharmaceutical Ingredient Market, by Manufacturer, by Region, 2016 - 2027 (USD Million)
- Table 4 Global Active Pharmaceutical Ingredient Market, by Application, by Region, 2016 - 2027 (USD Million)
- Table 5 Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016 - 2027 (USD Million)
- Table 6 North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 7 North America: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 8 North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 9 North America: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 10 U.S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 11 U.S.: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 12 U.S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 13 U.S.: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 14 Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 15 Canada: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 16 Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 17 Canada: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 18 Europe: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 19 Europe: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 20 Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 21 Europe: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 22 UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 23 UK: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 24 UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 25 UK: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 26 France: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 27 France: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 28 France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 29 France: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 30 Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 31 Germany: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 32 Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 33 Germany: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 34 Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 35 Italy: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 36 Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 37 Italy: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 38 Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 39 Netherlands: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 40 Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 41 Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 42 Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 43 Austria: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 44 Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 45 Austria: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 46 Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 47 Asia Pacific: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 48 Asia Pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 49 Asia Pacific: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 50 China: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 51 China: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 52 China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 53 China: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 54 India: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 55 India: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 56 India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 57 India: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 58 Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 59 Japan: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 60 Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 61 Japan: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 62 Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 63 Malaysia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 64 Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 65 Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 66 Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 67 Indonesia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 68 Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 69 Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 70 South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 71 South Korea: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 72 South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 73 South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 74 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 75 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 76 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 77 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 78 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 79 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 80 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 81 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 82 Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 83 Israel: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 84 Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 85 Israel: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 86 South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 87 South Africa: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 88 South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 89 South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 90 Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 91 Latin America: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 92 Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 93 Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 94 Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 95 Brazil: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 96 Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 97 Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 98 Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 99 Mexico: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 100 Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 101 Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
- Table 102 Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
- Table 103 Argentina: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
- Table 104 Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
- Table 105 Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
List of Figures
- Figure 1. Market Highlights (2019, Revenue)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top Down & Bottom Up Approach
- Figure 4. Market by Geography
- Figure 6. Porter's Five Forces
- Figure 7. Market by Product Type
- Figure 8. Global Active Pharmaceutical Ingredient Market, By Product Type, 2019 & 2027 (USD Million)
- Figure 9. Market by Form
- Figure 8. Global Active Pharmaceutical Ingredient Market, By Form, 2019 & 2027 (USD Million)
- Figure 9. Market by Manufacturer
- Figure 10. Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2019 & 2027 (USD Million)
- Figure 11. Market by Application
- Figure 12. Global Active Pharmaceutical Ingredient Market, By Application, 2019 & 2027 (USD Million)
- Figure 13. Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016- 2027 (USD Million)
- Figure 14. Strategic Analysis - Active Pharmaceutical Ingredient Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.